CINXE.COM

API | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

<!DOCTYPE html> <html class="no-js" lang="en"> <head><link rel="SHORTCUT ICON" href="/Media/30/Images/shortcut.ico" type="image/ico" /><title> API | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services </title><link rel="canonical" href="https://www.pharmoutsourcing.com/3736-API/" /> <meta name="description" content="API" /> <meta name="keywords" content="API, " /> <link type="text/css" rel="stylesheet" href="/rand-20241122020849/CommonStyleSheet.ashx" /><script type="text/javascript" src="/rand-20241122020849/AllSitesCommonJavaScript.ashx"> </script><meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1"> <script type="text/javascript" src="https://sadmin.brightcove.com/js/BrightcoveExperiences.js"></script> <script type="text/javascript" src="https://www.pharmoutsourcing.com/Media/30/Js/header_/po-omniture-242.js"></script> <meta name="google-site-verification" content="pqi6xVI-CmFz8ZMc5C4fcUMZ_nYpoyk0K-XtbQn-bKk" /> <!------ GoSquared ------> <script> !function(g,s,q,r,d){r=g[r]=g[r]||function(){(r.q=r.q||[]).push( arguments)};d=s.createElement(q);q=s.getElementsByTagName(q)[0]; d.src='//d1l6p2sc9645hc.cloudfront.net/tracker.js';q.parentNode. insertBefore(d,q)}(window,document,'script','_gs'); _gs('GSN-670983-Z'); </script> <!------ Google Ads ------> <script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script> <script> (adsbygoogle = window.adsbygoogle || []).push({ google_ad_client: "ca-pub-8592226654827380", enable_page_level_ads: true }); </script> <script async='async' src='https://www.googletagservices.com/tag/js/gpt.js'></script> <script> var googletag = googletag || {}; googletag.cmd = googletag.cmd || []; </script> <script async src="https://securepubads.g.doubleclick.net/tag/js/gpt.js"></script> <script> window.googletag = window.googletag || {cmd: []}; googletag.cmd.push(function() { googletag.defineSlot('/21803624868/PO_LDB_TOP', [728, 90], 'div-gpt-ad-1565115125252-0').addService(googletag.pubads()); googletag.pubads().enableSingleRequest(); googletag.enableServices(); }); </script> <!------ KaTeX by Douglas------> <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/katex@0.16.2/dist/katex.min.css" integrity="sha384-bYdxxUwYipFNohQlHt0bjN/LCpueqWz13HufFEV1SUatKs1cm4L6fFgCi1jT643X" crossorigin="anonymous"> <script defer src="https://cdn.jsdelivr.net/npm/katex@0.16.2/dist/katex.min.js" integrity="sha384-Qsn9KnoKISj6dI8g7p1HBlNpVx0I8p1SvlwOldgi3IorMle61nQy4zEahWYtljaz" crossorigin="anonymous"></script> <script defer src="https://cdn.jsdelivr.net/npm/katex@0.16.2/dist/contrib/auto-render.min.js" integrity="sha384-+VBxd3r6XgURycqtZ117nYw44OOcIax56Z4dCRWbxyPt0Koah1uHoK0o4+/RRE05" crossorigin="anonymous" onload="renderMathInElement(document.body);"></script> <!------ KaTeX SETUP end ------> </head> <body itemscope itemtype="http://schema.org/WebPage"> <!-- SiteCatalyst code version: H.24.2. Copyright 1996-2012 Adobe, Inc. All Rights Reserved More info available at http://www.omniture.com --> <script language="JavaScript" type="text/javascript"><!-- /* You may give each page an identifying name, server, and channel on the next lines. */ s.pageName="PO:API :API " s.server="10.1.1.13" s.channel="" s.pageType="" s.prop13="PO" s.prop14="D=ch" s.prop15="API " s.prop16="" s.prop17="API " /************* DO NOT ALTER ANYTHING BELOW THIS LINE ! **************/ var s_code=s.t();if(s_code)document.write(s_code)//--></script> <script language="JavaScript" type="text/javascript"><!-- if(navigator.appVersion.indexOf('MSIE')>=0)document.write(unescape('%3C')+'\!-'+'-') //--></script><noscript><img src="http://comparenetworks.112.2o7.net/b/ss/cn-pharmaceuticaloutsourcing/1/H.24.2--NS/0" height="1" width="1" border="0" alt="" /></noscript><!--/DO NOT REMOVE/--> <!-- End SiteCatalyst code version: H.24.2. --> <form name="frmMain" method="post" action="/3736-API/" id="frmMain" class="API subhomeList-page"> <div> <input type="hidden" name="__VIEWSTATE" id="__VIEWSTATE" value="/wEPDwUJNjUyMjEzODgzZBgBBR9jdGwwNiRjdGwyMCRjdGwwMSRtbnVOYXZpZ2F0aW9uDw9kBQZoaWRkZW5k7n87p4yTGuwjiOQAgrMfB7DNnyM=" /> </div> <script src="/WebResource.axd?d=dpIz1tUprODzzv20inh4BJEpgVUZm-xFDTggHx6QYA5KyoUf0eYDtpY-5v3MV7-YqZgVIWqIMVYe1KQYaMxNOa4kN6Q4zGHoJ-bIGU8rhqVTES-NGJ6gnzU9CVcRqWpDBWPUqZ4jjVrJAcrXfZnJTHObakYe8pAyZ1Gloq3Ir7xaZ64z0&amp;t=638662746645838159" type="text/javascript"></script> <div> <input type="hidden" name="__VIEWSTATEGENERATOR" id="__VIEWSTATEGENERATOR" value="CA0B0334" /> <input type="hidden" name="__EVENTVALIDATION" id="__EVENTVALIDATION" value="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" /> </div> <div class="twoColumnFiveRowLayout"> <header class="pageHeaderOuter HeaderOuter module"> <div id="ctl06_pageHeader" class="pageHeader"> <div class="login" id="divLogin"> <div class="welcome"> Welcome Guest<a id="lnkFlag" class="countryFlag" title="Singapore"><img id="imgCountryFlag" title="Singapore" alt="Singapore" src="https://media.pharmoutsourcing.com/cm/sg.gif" /></a> </div> <a id="ctl06_ctl17_lnkLoginPopup" title="Sign In" class="loginPopup">Sign In</a> <a id="ctl06_ctl17_lnkRegisterPopup" title="Register" class="register-link-non-modal" href="/1574-LoginRegister/?ru=https%3a%2f%2fwww.pharmoutsourcing.com%2f3736-API%2f&amp;urfd=2">Register</a> </div><a id="ctl06_ctl18_lnkHeader" title="Pharmaceutical Outsourcing" class="siteHeaderImage" href="/"><img id="ctl06_ctl18_imgHeader" title="Pharmaceutical Outsourcing" width="336" height="93" src="https://media.pharmoutsourcing.com/m/30/site/30.png" alt="Pharmaceutical Outsourcing" style="border-width:0px;" /></a> <div class="mobileMenu"><div id="ctl06_ctl19_staticHtml" class="staticHtmlModule module"><!--<div class="mobile-menu"> <div ><a id="toggle-nav" class="toggle-nav"></a></div> </div>--> <div class="mobile-menu"> <span id="toggle-nav" class="toggle-nav"></span> </div></div> </div><div id="ctl06_ctl20_divContainer" class="provider navContainer"> <div id="ctl06_ctl20_divHeader" class="header"> <h2> </h2> </div> <div class="subHomes categoryNavContainer"><div id="ctl06_ctl20_ctl00_staticHtml" class="staticHtmlModule module"><ul class="subHomesMenu menu"> <li class="active"><a title="Home" href="/">Home</a></li> <li><a title="API" href="/3736-API/">API</a></li> <li><a title="Manufacturing" href="/3737-Manufacturing/">Manufacturing</a></li> <li><a title="Clinical Trials" href="/3738-Clinical-Trials/">Clinical Trials</a></li> <li><a title="Analytical Testing" href="/3739-Analytical-Testing/">Analytical Testing</a></li> <li><a title="Cold Chain" href="/3740-Cold-Chain/">Cold Chain</a></li> </ul></div> </div> <nav class="navigaterMenu"> <div class="navMenu" id="ctl06_ctl20_ctl01_mnuNavigation"> <div class="menuHorizontal"> <ul class="menu"> <li class="first menuTrunk hasChild"><a href="/1562-ArticleList/" class="menuLink">Articles</a> <ul> <li class="first last menuLeaf"><a href="/3921-Facility-Tours/" class="menuLink">Facility Tours</a></li> </ul></li><li class="menuLeaf"><a href="/1585-News/" class="menuLink">News</a></li><li class="menuLeaf"><a href="/1625-Events/" class="menuLink">Events </a></li><li class="menuTrunk hasChild"><a href="/1587-Videos/" class="menuLink">Videos</a> <ul> <li class="first menuLeaf"><a href="/Clinical-Trials-Documentary/" class="menuLink">Clinical Trials Documentary</a></li><li class="last menuLeaf"><a href="/3878-Solid-Dosage-Future/" class="menuLink">A Solid Dosage Future Documentary</a></li> </ul></li><li class="menuLeaf"><a href="/1613-WhitePapers-ApplicationNotes/" class="menuLink">Whitepapers/App Notes</a></li><li class="menuLeaf"><a href="/1614-Archive-List/" class="menuLink">Issue Archives</a></li><li class="menuLeaf"><a href="/1624-Company-Focus/" class="menuLink">Company Focus</a></li><li class="menuLeaf"><a href="/1554-ProductDirectoryBranch/" class="menuLink">Service Directory</a></li><li data-on-click="Register" class="menuLeaf nav-menu-action nav-register"><a class="menuLink">Register</a></li><li data-on-click="SignIn" class="last menuLeaf nav-menu-action nav-log-in"><a class="menuLink">Sign In</a></li> </ul> </div> </div> </nav> </div> <div class="searchControl module"> <input id="txtSearchFor" type="text" class="textbox" autocomplete="off"/> <input id="btnSearch" type="button" value="Search" class="button searchButton" /> <input type='hidden' id='hdnSearchResultsPageUrl' value='/PO-General-Search/' /> </div> </div> </header> <div class="bodyContentOuter module"> <div class="bodyContent module"> <div id="ctl06_contentPaneHeader" class="contentPaneHeader"> <div class="leaderboard adContainer"><div id="ctl06_ctl01_staticHtml" class="staticHtmlModule module"><!-- AdGlare: PO Leaderboard --> <span id=zone732017079></span> <script async src='//comparenetworks.engine.adglare.net/?732017079'></script></div> </div> <nav class="breadcrumbMap" itemprop="breadcrumb" > <ul> <li><a href="/" title="Home">Home</a></li><li>API </li> </ul> </nav></div> <div class="contentPaneOuter module"> <div id="ctl06_contentPane" class="contentPane"> <div id="ctl06_ctl00_divContainer" class="container module primary mainArticleList"> <div class="header"> <h1> API</h1> </div> <div id="ctl06_ctl00_contentPane" class="content"> <div id="ctl06_ctl00_ctl00_staticHtml" class="staticHtmlModule module"><div class="floatRight" style="width: 200px; height: 120px;"><img src="https://media.pharmoutsourcing.com/m/30/category/3736-api-image.jpg" alt="PO API Capsule | API Pharmaceutical Outsourcing" width="200" height="120"></div> <p>An active pharmaceutical ingredient (API) is defined in ICH Q7 as “any substance or mixture of substances intended to be used in the manufacture of a drug product and that, when used in the production of a drug, becomes an active ingredient in the drug product. Such substances are intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment or prevention of disease or to affect the structure and function of the body.” </p> <p>Active pharmaceutical ingredients are distinguishable from inactive pharmaceutical ingredients, commonly known as excipients or formulation aids. </p> <p>The European Medicines Agency, and the US FDA have adopted the ICH Q7 definition of APIs.</p> <p>Many other terms are used interchangeably with API. They include: <ul><li>active </li><li> bulk pharmaceutical chemical </li><li> drug substance </li><li> active principle (especially for natural extracts) </li><li>therapeutic ingredient</li></ul></p> </div> <div id="ctl06_ctl00_ctl01_divArticleModule" class="articleModule"> <a id="ctl06_ctl00_ctl01_lnkScrollPosition" name="al30268"></a> <div id="ctl06_ctl00_ctl01_divArticleFilter" class="filter module"> <h4>Filter</h4> <a id="filterHeader" class="filterHeader">Hide Filter</a> <div id="filterBody" class="filterBody"> <div id="ctl06_ctl00_ctl01_vendorFilterDiv" class="vendors"> <select name="ctl06$ctl00$ctl01$ddlVendors" id="ctl06_ctl00_ctl01_ddlVendors" class="dropdownList" title="Select Company"> <option value="-1">Select Company</option> <option value="996">AAIPharma Services(3)</option> <option value="105043">Abbvie(1)</option> <option value="107039">Absorption Systems(2)</option> <option value="470">Accelovance(1)</option> <option value="105703">Adare Pharma Solutions(4)</option> <option value="105524">AdvantaPure(1)</option> <option value="10368">AdvantaPure&#174; NewAge&#174; Industries(1)</option> <option value="2141">Aesica(4)</option> <option value="105639">Ajinomoto Bio-Pharma Services(11)</option> <option value="898">Albany Molecular Research Inc (AMRI)(6)</option> <option value="106300">Albemarle Corporation(1)</option> <option value="106201">Alcami(7)</option> <option value="104763">Alkermes(3)</option> <option value="105011">Alkermes(3)</option> <option value="652">Almac(16)</option> <option value="104929">Almac Group(4)</option> <option value="104752">Alphora Research Inc.(1)</option> <option value="104610">AminoAcids.com(1)</option> <option value="106133">AMRI(10)</option> <option value="107418">Aphena Pharma Solutions(1)</option> <option value="831">Aptuit Inc(4)</option> <option value="10187">Ash Stevens(2)</option> <option value="105391">Ash Stevens(1)</option> <option value="104631">AstraZeneca Pharmaceuticals(12)</option> <option value="106276">Avara Pharmaceutical Services(1)</option> <option value="106298">Avara Pharmaceuticals(5)</option> <option value="106251">Bayer AG(4)</option> <option value="729">Beckloff Associates Inc(1)</option> <option value="1026">Ben Venue Laboratories Inc(1)</option> <option value="106254">BioAgilytix(1)</option> <option value="1233">BioClinica(6)</option> <option value="10377">Bioclinica(1)</option> <option value="105387">BioPlan Associates, Inc(1)</option> <option value="10375">BioPlan Associates, Inc.(8)</option> <option value="2540">BioStorage Technologies(1)</option> <option value="104685">Bird &amp; Bird LLP(1)</option> <option value="1683">Boehringer-Ingelheim GmbH(1)</option> <option value="10270">Boehringer-Ingelheim Pharma(1)</option> <option value="106224">Brammer Bio(1)</option> <option value="104633">Bristol-Myers Squibb, Co.(4)</option> <option value="105938">Calcott Consulting LLC(1)</option> <option value="508">Camargo Pharmaceutical Services(1)</option> <option value="104969">Camargo Pharmaceutical Services(2)</option> <option value="105671">Cambrex(2)</option> <option value="106345">Cambrex(18)</option> <option value="786">Cambridge Biomedical(1)</option> <option value="10227">Cambridge Major Laboratories, Inc(2)</option> <option value="105047">Capsugel(4)</option> <option value="105845">Cardinal Health(1)</option> <option value="104688">Catalent Pharma Solutions(43)</option> <option value="1045">Catalent Pharma Solutions(9)</option> <option value="104713">Cedarburg Hauser Pharmaceuticals(2)</option> <option value="104717">Celerion(4)</option> <option value="105232">Celgene(1)</option> <option value="104784">Cenduit(3)</option> <option value="106097">Cenduit(1)</option> <option value="602">Charles River(2)</option> <option value="104735">ChemCon GmbH(1)</option> <option value="105290">Chemical and Pharmaceutical Solutions(1)</option> <option value="546">ClinTec International(2)</option> <option value="105818">CMC Biologics(1)</option> <option value="1051">CMC Biologics A/S(1)</option> <option value="105773">CMCPlus(1)</option> <option value="106645">CMIC(2)</option> <option value="106488">Cobra Biologics(8)</option> <option value="1053">Cobra Biologics(1)</option> <option value="105833">Complya Asia Co., Ltd.(1)</option> <option value="105051">Cook Pharmica(2)</option> <option value="10167">Corden Pharma(1)</option> <option value="2111">CoreRx, Inc(1)</option> <option value="105672">CoreRx, Inc(1)</option> <option value="105516">CPhI(2)</option> <option value="105635">Crown Bioscience Inc.(1)</option> <option value="850">Crown Bioscience Inc.(2)</option> <option value="106132">Cryoport(1)</option> <option value="107420">Curia(1)</option> <option value="105644">Cytovance Biologics(3)</option> <option value="105334">Dalton Pharma Services(5)</option> <option value="2536">DHL Express(1)</option> <option value="1070">DPT Laboratories, Ltd.(1)</option> <option value="1685">DSM Pharmaceutical Products - Pharma Dosage Forms(1)</option> <option value="106041">Eckrich Consulting Services, LLC(1)</option> <option value="104967">Eli Lilly and Company(8)</option> <option value="105746">Emergent BioSolutions(2)</option> <option value="105963">Envigo(1)</option> <option value="106307">Epizyme, Inc.(1)</option> <option value="107223">Eurofins Alphora(1)</option> <option value="106336">Eurofins CDMO(3)</option> <option value="105338">European Consulting &amp; Contracting in Oncology(1)</option> <option value="10314">FDA(1)</option> <option value="105664">Federal Equipment(1)</option> <option value="106092">Fermion Oy(1)</option> <option value="1690">Ferro Pfanstiehl(1)</option> <option value="2064">Fluofarma(1)</option> <option value="105645">Fresenius Kabi Contract Manufacturing(5)</option> <option value="105715">Fujifilm Diosynth Biotechnologies(2)</option> <option value="105287">Genentech, Inc.(3)</option> <option value="106404">Glatt Air Techniques, Inc.(1)</option> <option value="104694">GlaxoSmithKline(4)</option> <option value="105646">Grand River Aseptic Manufacturing(7)</option> <option value="106222">Grifols Partnership(1)</option> <option value="105957">GSK(5)</option> <option value="105883">GxP Compliance &amp;Training Partners (GCTP)(2)</option> <option value="105013">Halo Pharmaceutical(1)</option> <option value="899">Harlan Laboratories(2)</option> <option value="1104">Hospira One 2 One(1)</option> <option value="106091">Hovione(1)</option> <option value="10378">ICON Clinical Research(4)</option> <option value="543">ICON plc(4)</option> <option value="10192">IGI Laboratories(2)</option> <option value="106501">IMS Health(1)</option> <option value="606">INC Research(8)</option> <option value="105515">INC Research(1)</option> <option value="10193">Intelsius(1)</option> <option value="105009">Interphex(1)</option> <option value="108033">Jeeva Clinical Trials, Inc.(2)</option> <option value="10194">JHP Pharmaceuticals(1)</option> <option value="105648">Jubilant HollisterStier Contract Manufacturing(1)</option> <option value="105940">Kevan Reeve Associates Group AB(1)</option> <option value="104755">LabCorp Clinical Trials(1)</option> <option value="104754">LifeConEx, LLC(1)</option> <option value="105430">Lonza(13)</option> <option value="107870">Lonza Biologics(2)</option> <option value="107491">Lonza Small Molecules(1)</option> <option value="105650">LSNE Contract Manufacturing(9)</option> <option value="106741">Lubrizol Life Science Health(3)</option> <option value="105676">Marken(1)</option> <option value="2529">Marken(3)</option> <option value="1250">Medidata Solutions Worldwide(1)</option> <option value="104698">Merck(7)</option> <option value="105885">Merck KGaA(8)</option> <option value="105652">Metrics Contract Services(3)</option> <option value="1130">Metrics Inc(1)</option> <option value="105653">Mikart, Inc.(1)</option> <option value="10374">Millennium Pharmaceuticals, Inc., The Takeda Oncology Company(1)</option> <option value="107115">Millipore Formulations(2)</option> <option value="106614">MilliporeSigma(1)</option> <option value="106833">Moravek(2)</option> <option value="104635">MRIGlobal(1)</option> <option value="105704">Myoderm(1)</option> <option value="106396">Nice Insight(12)</option> <option value="1141">Nippon Shikizai Inc.(1)</option> <option value="1144">Norwich Pharma Services(1)</option> <option value="105385">Novartis Pharmaceuticals(1)</option> <option value="10379">Novartis Vaccines &amp; Diagnostics(1)</option> <option value="1704">OSO BioPharmaceuticals Manufacturing, LLC(1)</option> <option value="106046">PAREXEL(3)</option> <option value="650">PAREXEL International(5)</option> <option value="107319">PCI(1)</option> <option value="106492">PCI Synthesis(17)</option> <option value="105694">Pelican BioThermal(1)</option> <option value="1154">Penn Pharmaceutical Services Ltd(1)</option> <option value="105649">Pfizer CentreOne(6)</option> <option value="1155">Pfizer CentreSource (PCS)(1)</option> <option value="10373">Pfizer, Inc.(10)</option> <option value="106036">Pharma &amp; Biopharma Outsourcing Association(3)</option> <option value="105939">Pharmatech Associates(6)</option> <option value="105753">PharmaTech Industries(1)</option> <option value="105667">Pii (Pharmaceutics International, Inc)(11)</option> <option value="106721">Piramal(8)</option> <option value="521">PPD Inc(4)</option> <option value="105138">PPD&#174; Laboratories(7)</option> <option value="105424">Purdue Pharma L.P.(1)</option> <option value="672">Quintiles(4)</option> <option value="106537">Quotient Sciences(3)</option> <option value="104553">ResearchDx(2)</option> <option value="676">Rho Inc(2)</option> <option value="10022">Roche(2)</option> <option value="106341">Roquette Pharma(1)</option> <option value="104682">Sanofi Pasteur Inc.(8)</option> <option value="105115">Sartorius Stedim(3)</option> <option value="105256">Sciformix Corporation(4)</option> <option value="107718">Scorpius BioManufacturing(2)</option> <option value="105637">SCYNEXIS, Inc.(1)</option> <option value="886">SCYNEXIS, Inc.(4)</option> <option value="106825">Seqens(8)</option> <option value="106347">Servier(1)</option> <option value="105386">SGL Chemistry Consulting(1)</option> <option value="105852">SGL Chemistry Consulting, LLC(3)</option> <option value="105710">SGS Life Science Services(3)</option> <option value="104739">SGS Life Science Services(2)</option> <option value="104859">Sigma-Aldrich(2)</option> <option value="697">Synexus Clinical Research Ltd.(1)</option> <option value="105832">Tara Innovations LLC(11)</option> <option value="105427">Temple University(1)</option> <option value="106308">TEVA Pharmaceutical Industries Ltd.(3)</option> <option value="105801">That&#39;s Nice(12)</option> <option value="105930">That’s Nice(1)</option> <option value="105767">The Beyond Group AG(1)</option> <option value="105505">Theorem Clinical Research(1)</option> <option value="106129">Thomson Reuters Life Sciences(2)</option> <option value="105401">Transposagen Biopharmaceuticals(1)</option> <option value="105230">Trials &amp; Training(1)</option> <option value="105887">Trials &amp; Training Consult(1)</option> <option value="10380">TTC, LLC(1)</option> <option value="105835">UPM Pharmaceuticals(1)</option> <option value="106128">Vantage Partners(1)</option> <option value="107126">Vectura(3)</option> <option value="10392">Vertex Pharmaceuticals(1)</option> <option value="104687">Vetter(6)</option> <option value="1225">Vetter Pharma International GmbH(1)</option> <option value="105658">Vetter Pharma International GmbH(1)</option> <option value="105717">Vifor Pharma(1)</option> <option value="105286">Voisin Consulting Life Sciences(1)</option> <option value="105118">Watson-Marlow(1)</option> <option value="1716">WuXi AppTec, Inc.(2)</option> <option value="1717">Xcelience(1)</option> <option value="104932">Xcelience(5)</option> <option value="10183">XenoTech(1)</option> </select> </div> <div id="ctl06_ctl00_ctl01_divCustomPropertyFilter" class="custom"> <select name="ctl06$ctl00$ctl01$ddlCustomProperty_30268_293" id="ctl06_ctl00_ctl01_ddlCustomProperty_30268_293" class="ddlCustomProperty_30268" title="Content Type"> <option value="-1">Select Content Type</option> <option value="Featured Article">Featured Article</option> <option value="News">News</option> <option value="Whitepaper">Whitepaper</option> <option value="Case Study">Case Study</option> <option value="Article">Article</option> </select></div> <div id="ctl06_ctl00_ctl01_divSearchGroupFilter" class="search-groups"> </div> <div class="filterButtons"> <input type="button" id="btnFilter" class="button" value="Filter" /> <input type="button" id="btnReset" class="button" value="Reset" /> </div> </div> </div> <div class="articleList module"> <span id="ctl06_ctl00_ctl01_lblMessage" class="errorMessage"></span> <ul class="articleList"> <li class="articleListRow module"><div class="articleListThumbnail"> <a title="Alloy Therapeutics and Takeda to Develop Cell Therapy Platform" href="/1315-News/616304-Alloy-Therapeutics-and-Takeda-to-Develop-Cell-Therapy-Platform/?catid=6263" rel="bookmark"><img itemprop="image" src="https://media.pharmoutsourcing.com/m/30/article/616304-134x100.jpg" onerror="this.onerror=null; this.src=&#39;https://media.pharmoutsourcing.com/m/30/article/articledefault.png&#39;" class="articleImage" title="Alloy Therapeutics and Takeda to Develop Cell Therapy Platform" width="134" height="100" /></a> </div><h4 class="articleListTitle entry-title"> <a href="/1315-News/616304-Alloy-Therapeutics-and-Takeda-to-Develop-Cell-Therapy-Platform/?catid=6263" title="Alloy Therapeutics and Takeda to Develop Cell Therapy Platform" rel="bookmark">Alloy Therapeutics and Takeda to Develop Cell Therapy Platform</a> </h4><div class="articleListCreated"> <abbr class="published" title="2024-11-21T00:00:00.0000000"> Thursday, November 21, 2024 </abbr> </div><div class="articleListSummary entry-summary"> Alloy Therapeutics Inc. announced a strategic collaboration and license agreement with Takeda Pharmaceutical Company to develop Takeda’s proprietary induced pluripotent stem cell (iPSC) derived CAR-T cell platform (iCAR-T) and iPSC-derived CAR-NK ... <a class="readMore" href="/1315-News/616304-Alloy-Therapeutics-and-Takeda-to-Develop-Cell-Therapy-Platform/?catid=6263" title="Alloy Therapeutics and Takeda to Develop Cell Therapy Platform" rel="bookmark">read more</a> </div></li><li class="articleListRow module alternatingRow"><div class="articleListThumbnail"> <a title="Vetter Strengthens Senior Management Team with Three Appointments" href="/1315-News/616307-Vetter-Strengthens-Senior-Management-Team-with-Three-Appointments/?catid=6263" rel="bookmark"><img itemprop="image" src="https://media.pharmoutsourcing.com/m/30/article/616307-134x100.jpg" onerror="this.onerror=null; this.src=&#39;https://media.pharmoutsourcing.com/m/30/article/articledefault.png&#39;" class="articleImage" title="Vetter Strengthens Senior Management Team with Three Appointments" width="134" height="100" /></a> </div><h4 class="articleListTitle entry-title"> <a href="/1315-News/616307-Vetter-Strengthens-Senior-Management-Team-with-Three-Appointments/?catid=6263" title="Vetter Strengthens Senior Management Team with Three Appointments" rel="bookmark">Vetter Strengthens Senior Management Team with Three Appointments</a> </h4><div class="articleListCreated"> <abbr class="published" title="2024-11-21T00:00:00.0000000"> Thursday, November 21, 2024 </abbr> </div><div class="articleListSummary entry-summary"> Vetter has announced the appointment of three senior leaders to take on the role of managing directors alongside Thomas Otto and Peter Soelkner. <a class="readMore" href="/1315-News/616307-Vetter-Strengthens-Senior-Management-Team-with-Three-Appointments/?catid=6263" title="Vetter Strengthens Senior Management Team with Three Appointments" rel="bookmark">read more</a> </div></li><li class="articleListRow module"><div class="articleListThumbnail"> <a title="NorthStar Medical Radioisotopes Executes Supply Agreement With Cellectar Biosciences for Therapeutic Radioisotope Actinium-225" href="/1315-News/616305-NorthStar-Medical-Radioisotopes-Executes-Supply-Agreement-With-Cellectar-Biosciences-for-Therapeutic-Radioisotope-Actinium-225/?catid=6263" rel="bookmark"><img itemprop="image" src="https://media.pharmoutsourcing.com/m/30/article/616305-134x100.jpg" onerror="this.onerror=null; this.src=&#39;https://media.pharmoutsourcing.com/m/30/article/articledefault.png&#39;" class="articleImage" title="NorthStar Medical Radioisotopes Executes Supply Agreement With Cellectar Biosciences for Therapeutic Radioisotope Actinium-225" width="134" height="100" /></a> </div><h4 class="articleListTitle entry-title"> <a href="/1315-News/616305-NorthStar-Medical-Radioisotopes-Executes-Supply-Agreement-With-Cellectar-Biosciences-for-Therapeutic-Radioisotope-Actinium-225/?catid=6263" title="NorthStar Medical Radioisotopes Executes Supply Agreement With Cellectar Biosciences for Therapeutic Radioisotope Actinium-225" rel="bookmark">NorthStar Medical Radioisotopes Executes Supply Agreement With Cellectar Biosciences for Therapeutic Radioisotope Actinium-225</a> </h4><div class="articleListCreated"> <abbr class="published" title="2024-11-21T00:00:00.0000000"> Thursday, November 21, 2024 </abbr> </div><div class="articleListSummary entry-summary"> NorthStar Medical Radioisotopes announced the signing of a strategic Master Supply Agreement with Cellectar Biosciences, Inc. under which Cellectar will acquire and integrate NorthStar’s n.c.a. Ac-225 into Cellectar’s proprietary Phospholipid Ethers ... <a class="readMore" href="/1315-News/616305-NorthStar-Medical-Radioisotopes-Executes-Supply-Agreement-With-Cellectar-Biosciences-for-Therapeutic-Radioisotope-Actinium-225/?catid=6263" title="NorthStar Medical Radioisotopes Executes Supply Agreement With Cellectar Biosciences for Therapeutic Radioisotope Actinium-225" rel="bookmark">read more</a> </div></li><li class="articleListRow module alternatingRow"><div class="articleListThumbnail"> <a title="GBI Biomanufacturing Expands Aseptic Fill-Finish Capabilities" href="/1315-News/616306-GBI-Biomanufacturing-Expands-Aseptic-Fill-Finish-Capabilities/?catid=6263" rel="bookmark"><img itemprop="image" src="https://media.pharmoutsourcing.com/m/30/article/616306-134x100.jpg" onerror="this.onerror=null; this.src=&#39;https://media.pharmoutsourcing.com/m/30/article/articledefault.png&#39;" class="articleImage" title="GBI Biomanufacturing Expands Aseptic Fill-Finish Capabilities" width="134" height="100" /></a> </div><h4 class="articleListTitle entry-title"> <a href="/1315-News/616306-GBI-Biomanufacturing-Expands-Aseptic-Fill-Finish-Capabilities/?catid=6263" title="GBI Biomanufacturing Expands Aseptic Fill-Finish Capabilities" rel="bookmark">GBI Biomanufacturing Expands Aseptic Fill-Finish Capabilities</a> </h4><div class="articleListCreated"> <abbr class="published" title="2024-11-21T00:00:00.0000000"> Thursday, November 21, 2024 </abbr> </div><div class="articleListSummary entry-summary"> GBI Biomanufacturing (GBI) announced the expansion of its Drug Product (DP) services, to include automated sterile fill and finish capabilities. GBI has the ability to support clients from clinical trials to commercial launch, for both Drug Substance... <a class="readMore" href="/1315-News/616306-GBI-Biomanufacturing-Expands-Aseptic-Fill-Finish-Capabilities/?catid=6263" title="GBI Biomanufacturing Expands Aseptic Fill-Finish Capabilities" rel="bookmark">read more</a> </div></li><li class="articleListRow module"><div class="articleListThumbnail"> <a title="Ardena’s Nanomedicine Facility Secures Full GMP Approval for Manufacturing" href="/1315-News/616217-Ardena-s-Nanomedicine-Facility-Secures-Full-GMP-Approval-for-Manufacturing/?catid=6263" rel="bookmark"><img itemprop="image" src="https://media.pharmoutsourcing.com/m/30/article/616217-134x100.jpg" onerror="this.onerror=null; this.src=&#39;https://media.pharmoutsourcing.com/m/30/article/articledefault.png&#39;" class="articleImage" title="Ardena’s Nanomedicine Facility Secures Full GMP Approval for Manufacturing" width="134" height="100" /></a> </div><h4 class="articleListTitle entry-title"> <a href="/1315-News/616217-Ardena-s-Nanomedicine-Facility-Secures-Full-GMP-Approval-for-Manufacturing/?catid=6263" title="Ardena’s Nanomedicine Facility Secures Full GMP Approval for Manufacturing" rel="bookmark">Ardena’s Nanomedicine Facility Secures Full GMP Approval for Manufacturing</a> </h4><div class="articleListCreated"> <abbr class="published" title="2024-11-19T00:00:00.0000000"> Tuesday, November 19, 2024 </abbr> </div><div class="articleListSummary entry-summary"> Ardena announced the full Good Manufacturing Practice (GMP) approval of its expanded nanomedicine facility in Oss, Netherlands. <a class="readMore" href="/1315-News/616217-Ardena-s-Nanomedicine-Facility-Secures-Full-GMP-Approval-for-Manufacturing/?catid=6263" title="Ardena’s Nanomedicine Facility Secures Full GMP Approval for Manufacturing" rel="bookmark">read more</a> </div></li><li class="articleListRow module alternatingRow"><div class="articleListThumbnail"> <a title="Safecor Health Acquires Viatris&#39; US Unit-Dose Packaging Business" href="/1315-News/616222-Safecor-Health-Acquires-Viatris-US-Unit-Dose-Packaging-Business/?catid=6263" rel="bookmark"><img itemprop="image" src="https://media.pharmoutsourcing.com/m/30/article/616222-134x100.jpg" onerror="this.onerror=null; this.src=&#39;https://media.pharmoutsourcing.com/m/30/article/articledefault.png&#39;" class="articleImage" title="Safecor Health Acquires Viatris&#39; US Unit-Dose Packaging Business" width="134" height="100" /></a> </div><h4 class="articleListTitle entry-title"> <a href="/1315-News/616222-Safecor-Health-Acquires-Viatris-US-Unit-Dose-Packaging-Business/?catid=6263" title="Safecor Health Acquires Viatris&#39; US Unit-Dose Packaging Business" rel="bookmark">Safecor Health Acquires Viatris' US Unit-Dose Packaging Business</a> </h4><div class="articleListCreated"> <abbr class="published" title="2024-11-19T00:00:00.0000000"> Tuesday, November 19, 2024 </abbr> </div><div class="articleListSummary entry-summary"> Safecor Health has acquired the U.S. unit-dose packaging business of Viatris Inc. The business was formerly known as Unit Dose Laboratories, or UDL. <a class="readMore" href="/1315-News/616222-Safecor-Health-Acquires-Viatris-US-Unit-Dose-Packaging-Business/?catid=6263" title="Safecor Health Acquires Viatris&#39; US Unit-Dose Packaging Business" rel="bookmark">read more</a> </div></li><li class="articleListRow module"><div class="articleListThumbnail"> <a title="Matica Biotechnology Appoints Chief Commercial Officer" href="/1315-News/616229-Matica-Biotechnology-Appoints-Chief-Commercial-Officer/?catid=6263" rel="bookmark"><img itemprop="image" src="https://media.pharmoutsourcing.com/m/30/article/616229-134x100.jpg" onerror="this.onerror=null; this.src=&#39;https://media.pharmoutsourcing.com/m/30/article/articledefault.png&#39;" class="articleImage" title="Matica Biotechnology Appoints Chief Commercial Officer" width="134" height="100" /></a> </div><h4 class="articleListTitle entry-title"> <a href="/1315-News/616229-Matica-Biotechnology-Appoints-Chief-Commercial-Officer/?catid=6263" title="Matica Biotechnology Appoints Chief Commercial Officer" rel="bookmark">Matica Biotechnology Appoints Chief Commercial Officer</a> </h4><div class="articleListCreated"> <abbr class="published" title="2024-11-19T00:00:00.0000000"> Tuesday, November 19, 2024 </abbr> </div><div class="articleListSummary entry-summary"> Matica Biotechnology, Inc. announced the appointment of Min Park, MBA as Chief Commercial Officer. <a class="readMore" href="/1315-News/616229-Matica-Biotechnology-Appoints-Chief-Commercial-Officer/?catid=6263" title="Matica Biotechnology Appoints Chief Commercial Officer" rel="bookmark">read more</a> </div></li><li class="articleListRow module alternatingRow"><div class="articleListThumbnail"> <a title="Pii Expands Prefilled Syringe Services with $3.6M Investment in Capacity and Technology Upgrades" href="/1315-News/616226-Pii-Expands-Prefilled-Syringe-Services-with-3-6M-Investment-in-Capacity-and-Technology-Upgrades/?catid=6263" rel="bookmark"><img itemprop="image" src="https://media.pharmoutsourcing.com/m/30/article/616226-134x100.jpg" onerror="this.onerror=null; this.src=&#39;https://media.pharmoutsourcing.com/m/30/article/articledefault.png&#39;" class="articleImage" title="Pii Expands Prefilled Syringe Services with $3.6M Investment in Capacity and Technology Upgrades" width="134" height="100" /></a> </div><h4 class="articleListTitle entry-title"> <a href="/1315-News/616226-Pii-Expands-Prefilled-Syringe-Services-with-3-6M-Investment-in-Capacity-and-Technology-Upgrades/?catid=6263" title="Pii Expands Prefilled Syringe Services with $3.6M Investment in Capacity and Technology Upgrades" rel="bookmark">Pii Expands Prefilled Syringe Services with $3.6M Investment in Capacity and Technology Upgrades</a> </h4><div class="articleListCreated"> <abbr class="published" title="2024-11-19T00:00:00.0000000"> Tuesday, November 19, 2024 </abbr> </div><div class="articleListSummary entry-summary"> Pharmaceutics International, Inc. announced a significant expansion of its prefilled syringe (PFS) capabilities with a $3.6 million investment in advanced labeling, fill/finish, and automated visual inspection technologies. <a class="readMore" href="/1315-News/616226-Pii-Expands-Prefilled-Syringe-Services-with-3-6M-Investment-in-Capacity-and-Technology-Upgrades/?catid=6263" title="Pii Expands Prefilled Syringe Services with $3.6M Investment in Capacity and Technology Upgrades" rel="bookmark">read more</a> </div></li><li class="articleListRow module"><div class="articleListThumbnail"> <a title="Benuvia Operations and Department of Veterans Affairs Sign CRADA Agreement" href="/1315-News/616124-Benuvia-Operations-and-Department-of-Veterans-Affairs-Sign-CRADA-Agreement/?catid=6263" rel="bookmark"><img itemprop="image" src="https://media.pharmoutsourcing.com/m/30/article/616124-134x100.jpg" onerror="this.onerror=null; this.src=&#39;https://media.pharmoutsourcing.com/m/30/article/articledefault.png&#39;" class="articleImage" title="Benuvia Operations and Department of Veterans Affairs Sign CRADA Agreement" width="134" height="100" /></a> </div><h4 class="articleListTitle entry-title"> <a href="/1315-News/616124-Benuvia-Operations-and-Department-of-Veterans-Affairs-Sign-CRADA-Agreement/?catid=6263" title="Benuvia Operations and Department of Veterans Affairs Sign CRADA Agreement" rel="bookmark">Benuvia Operations and Department of Veterans Affairs Sign CRADA Agreement</a> </h4><div class="articleListCreated"> <abbr class="published" title="2024-11-14T00:00:00.0000000"> Thursday, November 14, 2024 </abbr> </div><div class="articleListSummary entry-summary"> Benuvia Operations, an FDA registered, DEA licensed, and cGMP specializing in pharmaceutical cannabinoids, and the U.S. Department of Veterans Affairs Clinical Science Research and Development Service (VA CSRD) announced that the VA will conduct a ... <a class="readMore" href="/1315-News/616124-Benuvia-Operations-and-Department-of-Veterans-Affairs-Sign-CRADA-Agreement/?catid=6263" title="Benuvia Operations and Department of Veterans Affairs Sign CRADA Agreement" rel="bookmark">read more</a> </div></li><li class="articleListRow module alternatingRow"><div class="articleListThumbnail"> <a title="Aravax Establishes Pharmaceutical Development Base at the Oxford, UK Science Park" href="/1315-News/616125-Aravax-Establishes-Pharmaceutical-Development-Base-at-the-Oxford-UK-Science-Park/?catid=6263" rel="bookmark"><img itemprop="image" src="https://media.pharmoutsourcing.com/m/30/article/616125-134x100.jpg" onerror="this.onerror=null; this.src=&#39;https://media.pharmoutsourcing.com/m/30/article/articledefault.png&#39;" class="articleImage" title="Aravax Establishes Pharmaceutical Development Base at the Oxford, UK Science Park" width="134" height="100" /></a> </div><h4 class="articleListTitle entry-title"> <a href="/1315-News/616125-Aravax-Establishes-Pharmaceutical-Development-Base-at-the-Oxford-UK-Science-Park/?catid=6263" title="Aravax Establishes Pharmaceutical Development Base at the Oxford, UK Science Park" rel="bookmark">Aravax Establishes Pharmaceutical Development Base at the Oxford, UK Science Park</a> </h4><div class="articleListCreated"> <abbr class="published" title="2024-11-14T00:00:00.0000000"> Thursday, November 14, 2024 </abbr> </div><div class="articleListSummary entry-summary"> Aravax announced it has established a UK subsidiary, based on the Oxford Science Park, as the company continues its development into an international leader in food allergies. <a class="readMore" href="/1315-News/616125-Aravax-Establishes-Pharmaceutical-Development-Base-at-the-Oxford-UK-Science-Park/?catid=6263" title="Aravax Establishes Pharmaceutical Development Base at the Oxford, UK Science Park" rel="bookmark">read more</a> </div></li><li class="articleListRow module"><div class="articleListThumbnail"> <a title="Lonza to Expand Bioconjugation in Visp (CH) with Two Additional Manufacturing Suites" href="/1315-News/616062-Lonza-to-Expand-Bioconjugation-in-Visp-CH-with-Two-Additional-Manufacturing-Suites/?catid=6263" rel="bookmark"><img itemprop="image" src="https://media.pharmoutsourcing.com/m/30/article/616062-134x100.jpg" onerror="this.onerror=null; this.src=&#39;https://media.pharmoutsourcing.com/m/30/article/articledefault.png&#39;" class="articleImage" title="Lonza to Expand Bioconjugation in Visp (CH) with Two Additional Manufacturing Suites" width="134" height="100" /></a> </div><h4 class="articleListTitle entry-title"> <a href="/1315-News/616062-Lonza-to-Expand-Bioconjugation-in-Visp-CH-with-Two-Additional-Manufacturing-Suites/?catid=6263" title="Lonza to Expand Bioconjugation in Visp (CH) with Two Additional Manufacturing Suites" rel="bookmark">Lonza to Expand Bioconjugation in Visp (CH) with Two Additional Manufacturing Suites</a> </h4><div class="articleListCreated"> <abbr class="published" title="2024-11-12T00:00:00.0000000"> Tuesday, November 12, 2024 </abbr> </div><div class="articleListSummary entry-summary"> Lonza announced it will invest in additional bioconjugation capabilities in Visp (CH). The expansion will add two multipurpose 1,200L manufacturing suites and manufacturing-related infrastructure to the?existing bioconjugation facility in Visp (CH) ... <a class="readMore" href="/1315-News/616062-Lonza-to-Expand-Bioconjugation-in-Visp-CH-with-Two-Additional-Manufacturing-Suites/?catid=6263" title="Lonza to Expand Bioconjugation in Visp (CH) with Two Additional Manufacturing Suites" rel="bookmark">read more</a> </div></li><li class="articleListRow module alternatingRow"><div class="articleListThumbnail"> <a title="Gilero Expands Injection Molding Capabilities with New Facility in Greensboro, NC" href="/1315-News/616064-Gilero-Expands-Injection-Molding-Capabilities-with-New-Facility-in-Greensboro-NC/?catid=6263" rel="bookmark"><img itemprop="image" src="https://media.pharmoutsourcing.com/m/30/article/616064-134x100.jpg" onerror="this.onerror=null; this.src=&#39;https://media.pharmoutsourcing.com/m/30/article/articledefault.png&#39;" class="articleImage" title="Gilero Expands Injection Molding Capabilities with New Facility in Greensboro, NC" width="134" height="100" /></a> </div><h4 class="articleListTitle entry-title"> <a href="/1315-News/616064-Gilero-Expands-Injection-Molding-Capabilities-with-New-Facility-in-Greensboro-NC/?catid=6263" title="Gilero Expands Injection Molding Capabilities with New Facility in Greensboro, NC" rel="bookmark">Gilero Expands Injection Molding Capabilities with New Facility in Greensboro, NC</a> </h4><div class="articleListCreated"> <abbr class="published" title="2024-11-12T00:00:00.0000000"> Tuesday, November 12, 2024 </abbr> </div><div class="articleListSummary entry-summary"> Gilero, a Sanner Group Company, is expanding its manufacturing capabilities with a new 60,500 square foot (5,620 square meter) facility in Greensboro, North Carolina. <a class="readMore" href="/1315-News/616064-Gilero-Expands-Injection-Molding-Capabilities-with-New-Facility-in-Greensboro-NC/?catid=6263" title="Gilero Expands Injection Molding Capabilities with New Facility in Greensboro, NC" rel="bookmark">read more</a> </div></li><li class="articleListRow module"><div class="articleListThumbnail"> <a title="Adragos Pharma Completes Expansion with New Ampoule Fill and Finish Line in Livron, France" href="/1315-News/616063-Adragos-Pharma-Completes-Expansion-with-New-Ampoule-Fill-and-Finish-Line-in-Livron-France/?catid=6263" rel="bookmark"><img itemprop="image" src="https://media.pharmoutsourcing.com/m/30/article/616063-134x100.jpg" onerror="this.onerror=null; this.src=&#39;https://media.pharmoutsourcing.com/m/30/article/articledefault.png&#39;" class="articleImage" title="Adragos Pharma Completes Expansion with New Ampoule Fill and Finish Line in Livron, France" width="134" height="100" /></a> </div><h4 class="articleListTitle entry-title"> <a href="/1315-News/616063-Adragos-Pharma-Completes-Expansion-with-New-Ampoule-Fill-and-Finish-Line-in-Livron-France/?catid=6263" title="Adragos Pharma Completes Expansion with New Ampoule Fill and Finish Line in Livron, France" rel="bookmark">Adragos Pharma Completes Expansion with New Ampoule Fill and Finish Line in Livron, France</a> </h4><div class="articleListCreated"> <abbr class="published" title="2024-11-12T00:00:00.0000000"> Tuesday, November 12, 2024 </abbr> </div><div class="articleListSummary entry-summary"> Adragos Pharmahas enhanced its production capabilities with the completion of a new ampoule filling line at its Livron-sur-Drôme site in France. <a class="readMore" href="/1315-News/616063-Adragos-Pharma-Completes-Expansion-with-New-Ampoule-Fill-and-Finish-Line-in-Livron-France/?catid=6263" title="Adragos Pharma Completes Expansion with New Ampoule Fill and Finish Line in Livron, France" rel="bookmark">read more</a> </div></li><li class="articleListRow module alternatingRow"><div class="articleListThumbnail"> <a title="BrainStorm Cell Therapeutics and Pluri Partner to Support Phase 3b Trial Manufacturing of ALS Treatment" href="/1315-News/616066-BrainStorm-Cell-Therapeutics-and-Pluri-Partner-to-Support-Phase-3b-Trial-Manufacturing-of-ALS-Treatment/?catid=6263" rel="bookmark"><img itemprop="image" src="https://media.pharmoutsourcing.com/m/30/article/616066-134x100.jpg" onerror="this.onerror=null; this.src=&#39;https://media.pharmoutsourcing.com/m/30/article/articledefault.png&#39;" class="articleImage" title="BrainStorm Cell Therapeutics and Pluri Partner to Support Phase 3b Trial Manufacturing of ALS Treatment" width="134" height="100" /></a> </div><h4 class="articleListTitle entry-title"> <a href="/1315-News/616066-BrainStorm-Cell-Therapeutics-and-Pluri-Partner-to-Support-Phase-3b-Trial-Manufacturing-of-ALS-Treatment/?catid=6263" title="BrainStorm Cell Therapeutics and Pluri Partner to Support Phase 3b Trial Manufacturing of ALS Treatment" rel="bookmark">BrainStorm Cell Therapeutics and Pluri Partner to Support Phase 3b Trial Manufacturing of ALS Treatment</a> </h4><div class="articleListCreated"> <abbr class="published" title="2024-11-12T00:00:00.0000000"> Tuesday, November 12, 2024 </abbr> </div><div class="articleListSummary entry-summary"> BrainStorm Cell Therapeutics Inc. has entered into a Memorandum of Understanding (MOU) with Pluri Inc. to manufacture NurOwn® for use in BrainStorm's planned Phase 3b trial in amyotrophic lateral sclerosis (ALS). <a class="readMore" href="/1315-News/616066-BrainStorm-Cell-Therapeutics-and-Pluri-Partner-to-Support-Phase-3b-Trial-Manufacturing-of-ALS-Treatment/?catid=6263" title="BrainStorm Cell Therapeutics and Pluri Partner to Support Phase 3b Trial Manufacturing of ALS Treatment" rel="bookmark">read more</a> </div></li><li class="articleListRow module"><div class="articleListThumbnail"> <a title="Evotec Sells API Manufacturing Facility" href="/1315-News/616017-Evotec-Sells-API-Manufacturing-Facility/?catid=6263" rel="bookmark"><img itemprop="image" src="https://media.pharmoutsourcing.com/m/30/article/616017-134x100.jpg" onerror="this.onerror=null; this.src=&#39;https://media.pharmoutsourcing.com/m/30/article/articledefault.png&#39;" class="articleImage" title="Evotec Sells API Manufacturing Facility" width="134" height="100" /></a> </div><h4 class="articleListTitle entry-title"> <a href="/1315-News/616017-Evotec-Sells-API-Manufacturing-Facility/?catid=6263" title="Evotec Sells API Manufacturing Facility" rel="bookmark">Evotec Sells API Manufacturing Facility</a> </h4><div class="articleListCreated"> <abbr class="published" title="2024-11-07T00:00:00.0000000"> Thursday, November 07, 2024 </abbr> </div><div class="articleListSummary entry-summary"> Evotec SE announced the sale of its chemical API manufacturing site to Monacum Partners GmbH - a Munich-based Private Equity firm. <a class="readMore" href="/1315-News/616017-Evotec-Sells-API-Manufacturing-Facility/?catid=6263" title="Evotec Sells API Manufacturing Facility" rel="bookmark">read more</a> </div></li> </ul> </div> <div id="ctl06_ctl00_ctl01_divViewMoreLink" class="viewMoreLink"> </div> <div class="pager"><div class="pagingHolder module"><div class="pageTitle">Page</div><ul class="pages module"><li class="previousSection"><<</li><li class="previous"><</li><li class="active">1</li><li><a href="/3736-API/?alpi_30268=2" title="Page 2">2</a></li><li><a href="/3736-API/?alpi_30268=3" title="Page 3">3</a></li><li><a href="/3736-API/?alpi_30268=4" title="Page 4">4</a></li><li><a href="/3736-API/?alpi_30268=5" title="Page 5">5</a></li><li class="next"><a href="/3736-API/?alpi_30268=2" title="Next Page">></a></li><li class="nextSection"><a href="/3736-API/?alpi_30268=6" title="Next Section">>></a></li></ul></div></div> </div> </div> </div> </div> </div> <div class="leftSidebarOuter module"> <div id="ctl06_leftSidebar" class="leftSidebar"> <div class="adContainer mediumRectangle one"><div id="ctl06_ctl07_staticHtml" class="staticHtmlModule module"><!-- AdGlare: PO RMR1 --> <span id=zone282695571></span> <script async src='//comparenetworks.engine.adglare.net/?282695571'></script></div> </div><div id="ctl06_ctl08_divContainer" class="container module default adContainer mediumRectangle"> <div id="ctl06_ctl08_divHeader" class="header"> <h2> </h2> </div> <div id="ctl06_ctl08_contentPane" class="content"> <div id="ctl06_ctl08_ctl00_staticHtml" class="staticHtmlModule module"><!-- AdGlare: PO RMR 377794806 --> <span id=zone377794806></span> <script async src='//comparenetworks.engine.adglare.net/?377794806'></script></div> </div> </div> <div class="subscription"><div id="ctl06_ctl09_staticHtml" class="staticHtmlModule module"><div class="content"> <h2> Subscriptions</h2> <a href="https://www.b2bmediaportal.com/DynamicRegister/Register.aspx?fid=APOF" target="_blank"> <img alt="Get started here for yourcomplimentary print ordigital subscription" style="border: none; margin: -37px 0 5px 0;" src="/Media/30/Images/Subscription.jpg"> Get started here for your complimentary print or<br /> digital subscription </a> <a href="https://www.b2bmediaportal.com/DynamicRegister/Register.aspx?fid=APOF" target="_blank" class="newsletter" >Sign up Now &raquo;</a> </div></div> </div><div id="ctl06_ctl10_divContainer" class="container module default "> <div id="ctl06_ctl10_divHeader" class="header"> <h2> 2024 Contract Services Directory and Guide </h2> </div> <div id="ctl06_ctl10_contentPane" class="content"> <div id="ctl06_ctl10_ctl00_staticHtml" class="staticHtmlModule module"><ul class="articleList" style=" margin: 0; padding:0; list-style-type: none;"> <li class="articleListRow" style=" padding: 0; margin: 0 auto; width: 175px;"><div class="articleListThumbnail"> <a title="2024 Contract Services Directory and Guide " href="https://www.pharmoutsourcing.com/1614-Archive-List/609725-2024-Contract-Services-Directory-and-Guide/" target="_blank" rel="bookmark"><img itemprop="image" src="https://media.pharmoutsourcing.com/m/30/article/609725-600x800.jpg" onerror="this.onerror=null; this.src='https://media.tabletscapsules.com/m/54/article/articledefault.png'" class="articleImage" title="2024 Contract Services Directory and Guide" width="175" height="235" style="border:1px solid black;"></a> </div><h4 class="articleListTitle" style=" margin: 10px 0;"> <a href="https://www.pharmoutsourcing.com/1614-Archive-List/609725-2024-Contract-Services-Directory-and-Guide/" target=" _blank" =""="" title="2024 Annual Buyer’s Guide " rel="bookmark">2024 Contract Services Directory and Guide </a> </h4> <a class="readMore" href="https://www.pharmoutsourcing.com/1614-Archive-List/609725-2024-Contract-Services-Directory-and-Guide/" title="2024 Contract Services Directory and Guide" rel="bookmark" style=" background: linear-gradient(#0087a0,#005e81)!important; color: #fff; padding: 5px 10px; display: block; width: 64px; height: 20px; margin: 0 auto; border-radius: 3px;">View Issue</a> </li> </ul></div> </div> </div> <div id="ctl06_ctl11_divContainer" class="container module default "> <div id="ctl06_ctl11_divHeader" class="header"> <h2> Connect with Us</h2> </div> <div id="ctl06_ctl11_contentPane" class="content"> <div id="ctl06_ctl11_ctl00_staticHtml" class="staticHtmlModule module"><ul class="stayConnected flex-container"> <li class="facebook"><a href="https://www.facebook.com/PharmaceuticalOutsourcing" target="_blank" rel="nofollow" title="facebook">facebook</a></li> <li class="Linkedin"><a href="https://www.linkedin.com/company/pharmaceutical-outsourcing/" target="_blank" rel="nofollow" title="Linkedin" >Linkedin</a></li> <li class="twitter"><a href="https://twitter.com/PharmOutsource" target="_blank" rel="nofollow" title="Twitter" ><img src="/Media/30/Images/svg/x-logo.svg"></a></li> <li class="youTube"><a href="http://www.youtube.com/channel/UCRjiBbP8qtiJYqa6H6_Kiiw" target="_blank" rel="nofollow" title="YouTube" >YouTube</a></li> </ul> </div> </div> </div> <div class="adContainer mediumRectangle three"><div id="ctl06_ctl12_staticHtml" class="staticHtmlModule module"><!-- AdGlare: PO RMR3 --> <span id=zone158878137></span> <script async src='//comparenetworks.engine.adglare.net/?158878137'></script></div> </div><div class="adContainer mediumRectangle two"><div id="ctl06_ctl13_staticHtml" class="staticHtmlModule module"><!-- AdGlare: PO RMR2 --> <span id=zone524087642></span> <script async src='//comparenetworks.engine.adglare.net/?524087642'></script></div> </div><div id="ctl06_ctl14_divContainer" class="container module default adContainer mediumRectangle"> <div id="ctl06_ctl14_contentPane" class="content"> <div id="ctl06_ctl14_ctl00_staticHtml" class="staticHtmlModule module"><!-- AdGlare: PO RMR3 --> <span id=zone158878137></span> <script async src='//comparenetworks.engine.adglare.net/?158878137'></script></div> </div> </div> <div class="adContainer mediumRectangle four"><div id="ctl06_ctl15_staticHtml" class="staticHtmlModule module"><!-- AdGlare: PO RMR4 --> <span id=zone564086791></span> <script async src='//comparenetworks.engine.adglare.net/?564086791'></script></div> </div><div id="ctl06_ctl16_divContainer" class="container module default follow"> <div id="ctl06_ctl16_divHeader" class="header"> <h2> <a href="/PO-Newsletter-Signup/" title="Sign up for our eNewsletter!">Sign up for our eNewsletter!</a></h2> </div> <div id="ctl06_ctl16_contentPane" class="content"> <div id="ctl06_ctl16_ctl00_staticHtml" class="staticHtmlModule module"><p> Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.</p> <div class="subscribe module"> <input id="txtSubscribe" type="text" class="textbox" /> <input id="btnSubscribe" type="button" value="Subscribe" class="subscribeButton" /> </div></div> </div> </div> </div> </div> </div> </div> <footer class="footerOuter module"> <div id="ctl06_footer" class="footer"> <div id="ctl06_ctl03_staticHtml" class="staticHtmlModule module"><style> .wallpaper-ad { position: absolute; width: 1445px; height: 590px; max-width: fit-content; top: 185px; border: none; inset: 185px 0 0; z-index: 0; margin-left: auto; margin-right: auto; } .twoColumnLayout .leftSidebarOuter .leftSidebar { display:block !important; } </style> <script> // Wallpaper Ad (function () { var Collider = { makeSticky: function (margin) { $('.wallpaper-ad').css({ 'position': 'absolute', 'margin-top': margin - 260 + 'px' }); }, makeFloaty: function (margin) { $('.wallpaper-ad').css({ 'position': 'fixed', 'margin-top': margin - 50 + 'px' }); }, initScroll: function () { if ($(window).width() > 760) { // Desktop only var lastScrollPos = 0; $(window).scroll(function () { var thisScrollPos = $(this).scrollTop(); if (thisScrollPos > lastScrollPos) { Collider.checkDownScroll(); } else { Collider.checkUpScroll(); } lastScrollPos = thisScrollPos; }); } }, checkDownScroll: function () { var collider = $('.wallpaper-ad').height() + $('.wallpaper-ad').offset().top + 30, fense = $('footer').offset().top; if (collider >= fense) { this.makeSticky($('.footer').offset().top - $('.wallpaper-ad').height()); } }, checkUpScroll: function () { var fense = $('footer').offset().top - $('.wallpaper-ad').height() - 148; if ($(window).scrollTop() <= fense) { this.makeFloaty(118); } } }; Collider.initScroll(); })(); </script> </div> <div class="baseboard adContainer"><div id="ctl06_ctl04_staticHtml" class="staticHtmlModule module"><!-- AdGlare: PO Floating Banner --> <span id=zone467266134></span> <script async src='//comparenetworks.engine.adglare.net/?467266134'></script> </div> </div><div id="ctl06_ctl05_divFooter"><div class="footer-html"> <div class="footerColumn first"> <img src="https://www.pharmoutsourcing.com/Media/30/Images/FooterLogo.gif" style="max-width: 235px;" alt="Pharmaceutical Outsourcing"> <p> Pharmaceutical Outsourcing is the leading review of business and technology for the pharmaceutical industry throughout North America.<br> <br> <img src="https://media.pharmoutsourcing.com/m/30/site/po_25th_anniversary.png" style="max-width: 235px;" alt="Pharmaceutical Outsourcing 25th anniversary"><br> A Publication of <a href="http://corp.comparenetworks.com" title="A Site by CompareNetworks" rel="nofollow" style="display: block;" target="_blank"> <img style="border: none; width: 180px;" src="/Media/28/Images/cn_retina.png" alt="A Site by CompareNetworks" /></a> <a title="See our other sites »" href="/2212-CompareNetworks/"><b>See our other sites »</b></a> </p> <h4> Connect with Us </h4> <div class="FL-Article"> <div class="ContentSharing"> <a target="_blank" href="https://twitter.com/PharmOutsource"> <span class="tweets"> <img alt="X" src="https://www.pharmoutsourcing.com/Media/30/Images/svg/x-logo-white.svg" width="15px" /> </span> </a> <a target="_blank" href="https://www.facebook.com/PharmaceuticalOutsourcing"> <span class="facebook"> <img alt="facebook" src="https://www.pharmoutsourcing.com/Media/30/Images/svg/facebook-white.svg" width="25px" height="25px" /> </span> </a> <a target="_blank" href="https://www.linkedin.com/company/pharmaceutical-outsourcing/"> <span class="linkedin"> <img src="https://www.pharmoutsourcing.com/Media/30/Images/svg/linkedin-white.svg" alt="linkedin" width="25px" height="25px" /> </span></a> <a title="YouTube" target="_blank" href="https://www.youtube.com/channel/UCRjiBbP8qtiJYqa6H6_Kiiw" rel="nofollow"> <span class="youtube"><img alt="YouTube" src="https://www.pharmoutsourcing.com/Media/30/Images/svg/youtube-white.svg" width="30px" height="30px" style="margin-top: -7px;" /> </span> </div> </a> </div> <p class="copyright"> Copyright &copy; 2024 <a href="http://corp.comparenetworks.com" title="CompareNetworks Corporate Site" rel="nofollow" target="_blank">CompareNetworks, Inc</a>. All rights reserved. </p> </div> <div class="footerColumn"> <h4> About PO </h4> <ul class="menu" style="margin-bottom: 35px;"> <li><a href="/1610-About-Us/" title="About Pharmaceutical Outsourcing">About Us</a> </li> <li><a href="/1592-Contact-Us/" title="Contact Pharmaceutical Outsourcing" rel="nofollow">Contact Us</a> </li> <li><a href="/1604-Press-Room/" title="Press Room" rel="nofollow">Press Room</a> </li> <li class="first"><a href="/1594-Privacy-Policy/" title="Pharmaceutical Outsourcing Privacy Policy" rel="nofollow">Privacy Policy</a> </li> <li><a href="/1595-Disclaimer-Terms-of-Use/" title="Pharmaceutical Outsourcing Disclaimer" rel="nofollow">Disclaimer</a> </li> </ul> <h4> Advertise with Us </h4> <ul class="menu"> <li><a href="https://comparenetworks.wufoo.com/forms/request-a-media-kit-qnyb16c1gpdf5j" target=_blank title="Request Media Kit" rel="nofollow">Media Kit Request</a> </li> </ul> </div> <div class="footerColumn"> <h4> Resources </h4> <ul class="menu"> <li><a title="Issue Archive" href="/1614-Archive-List/">Issue Archive </a></li> <li><a title="Service Directory" href="https://www.pharmoutsourcing.com/1554-ProductDirectoryBranch/">Service Directory </a></li> <li><a title="Issue Archive" href="https://www.pharmoutsourcing.com/3878-Solid-Dosage-Future/">Solid Dosage Documentary</a></li> <li><a title="API" href="/3736-API/">API</a> </li> <li><a title="Manufacturing" href="/3737-Manufacturing/">Manufacturing</a> </li> <li><a title="Clinical Trials" href="/3738-Clinical-Trials/">Clinical Trials</a></li> <li><a title="Analytical Testing" href="/3739-Analytical-Testing/">Analytical Testing</a> </li> <li><a title="Cold Chain" href="/3740-Cold-Chain/">Cold Chain</a></li> </ul> </div> <div class="footerColumn"> <h4> Subscription </h4> <ul class="menu"> <ul class="menu" style="margin-bottom: 35px;"> <li><a title="Subscribe eNewsletters" href="/PO-Newsletter-Signup/">Subscribe eNewsletters</a> </li> <li><a title="Subscribe Magazine" target="_blank" href="http://www.b2bmediaportal.com/dynamicregister/register.aspx?fid=APOF&status=NEW">Subscribe Magazine</a> </li> <li><a target="_blank" href="http://www.b2bmediaportal.com/dynamicregister/register.aspx?fid=APOF">Manage Your Print Subscription</a></li> </ul> </div> </div></div><div id="ctl06_ctl06_staticHtml" class="staticHtmlModule module"><style> .jqmWindow.jqmID1 .formList .description{ white-space: nowrap; text-align: left; } .jqmWindow.jqmID1 .formHolder ul li { display: block; } .jqmWindow.jqmID1 .formHolder { padding: 0; margin: 30px 0 0 0 !important; } .jqmWindow.jqmID1 .leftLabel li div.inputElements{ width: auto; } </style></div> </div> </footer> </div> <div id="modalPopup" class="jqmWindow"> </div> <script type="text/javascript"> //<![CDATA[ MakeHoverMenu('ctl06_ctl20_ctl01_mnuNavigation');//]]> </script> </form> <script src="https://ak.sail-horizon.com/spm/spm.v1.min.js"></script> <script type="text/javascript">try{ Sailthru.init({ customerId: "6b0e3918dfddbec7995c67ba4e3ffdf1" ,isCustom: true, autoTrackPageview: false, useStoredTags: false }); } catch(err){ console.warn('sailthru initialization failed'); } </script> <script type="text/javascript">VP.BaseUrl = '/';VP.AjaxWebServiceUrl = '/WebServices/AjaxService.asmx';VP.SiteId = 30;VP.PageId = 3736;VP.PredefinedPageId = 0;</script><script type="text/javascript"> $("#divLogin").append($("<a class='subscribeHeader' href='https://www.b2bmediaportal.com/DynamicRegister/Register.aspx?fid=APOF' target='_blank'>Subscribe</a>"));</script> <script> (function (d, s, id) { var js, fjs = d.getElementsByTagName(s)[0]; if (d.getElementById(id)) return; js = d.createElement(s); js.id = id; js.src = "//connect.facebook.net/en_US/all.js#xfbml=1"; fjs.parentNode.insertBefore(js, fjs); } (document, 'script', 'facebook-jssdk')); </script><script type="text/javascript"> $(document).ready(function() {VP.Login.CurrentPageUrl = 'https://www.pharmoutsourcing.com/3736-API/'; VP.Login.SiteUrl = 'https://www.pharmoutsourcing.com//';VP.Login.PasswordResetPageUrl = 'https://www.pharmoutsourcing.com/1571-PasswordReset/';VP.Login.CountryId = 187;VP.Login.IsLogged = 'false';VP.Login.UserProfilePage = '/1568-UserProfile/';VP.Login.UserProfilePageFromCountryFlag = '/1568-UserProfile/?upti=profile';VP.Login.DefaultAdminContactEmail = 'helpdesk@comparenetworks.com';$(document).ready(function(){var articleList30268 = new VP.ArticleList('30268', 'ctl06_ctl00_ctl01_divArticleModule',false,true,true,false);});window.truncationLength =30;});</script> <script type="text/javascript" src="/rand-20241122020849/AllSitesCommonFooterJavaScript.ashx"> </script> <script type="text/javascript" src="/rand-20241122020849/CommonJavaScript.ashx"> </script> <script type="text/javascript" src="/rand-20241122020849/keys-i-j-k-d/ControlJavaScript.ashx"> </script> </body> </html>

Pages: 1 2 3 4 5 6 7 8 9 10